|
APGE
|
US |
APOGEE THERAPEUTICS INC |
8,493,321 |
$385M |
26.40% |
-
|
- |
|
OCUL
|
US |
OCULAR THERAPEUTIX INC |
12,762,462 |
$109M |
7.48% |
-
|
- |
|
ELVN
|
US |
ENLIVEN THERAPEUTICS INC |
4,026,331 |
$91M |
6.22% |
-
|
- |
|
PRAX
|
US |
PRAXIS PRECISION MEDICINES I |
989,985 |
$76M |
5.23% |
40.2%
|
- |
|
VRDN
|
US |
VIRIDIAN THERAPEUTICS INC |
3,882,709 |
$74M |
5.11% |
-
|
- |
|
ORKA
|
US |
ORUKA THERAPEUTICS INC |
3,285,620 |
$64M |
4.37% |
6.5%
|
- |
|
SYRE
|
US |
SPYRE THERAPEUTICS INC |
2,685,448 |
$63M |
4.29% |
-
|
- |
|
PHVS
|
US |
PHARVARIS NV |
3,220,130 |
$62M |
4.24% |
-5.2%
|
- |
|
KALV
|
US |
KALVISTA PHARMACEUTICALS INC |
6,249,731 |
$53M |
3.63% |
-
|
- |
|
DYN
|
US |
DYNE THERAPEUTICS INC |
2,173,913 |
$51M |
3.51% |
-
|
- |
|
COGT
|
US |
COGENT BIOSCIENCES INC |
5,684,411 |
$44M |
3.04% |
0.0%
|
- |
|
ERAS
|
US |
ERASCA INC |
16,216,216 |
$41M |
2.79% |
-
|
- |
|
DNTH
|
US |
DIANTHUS THERAPEUTICS INC |
1,744,373 |
$38M |
2.61% |
-
|
- |
|
91678A107
|
- |
UPSTREAM BIO INC |
2,295,319 |
$38M |
2.59% |
100.0%
|
- |
|
ORIC
|
US |
ORIC PHARMACEUTICALS INC |
4,394,527 |
$35M |
2.43% |
-
|
- |
|
ENGN
|
US |
ENGENE HOLDINGS INC |
5,046,414 |
$34M |
2.30% |
41.5%
|
- |
|
MRUS
|
US |
MERUS NV |
592,411 |
$25M |
1.71% |
-34.8%
|
- |
|
ATXS
|
US |
ASTRIA THERAPEUTICS INC |
2,457,348 |
$22M |
1.51% |
-29.0%
|
- |
|
CDTX
|
US |
CIDARA THERAPEUTICS INC |
765,723 |
$21M |
1.41% |
100.0%
|
- |
|
CGEM
|
US |
CULLINAN THERAPEUTICS INC |
1,379,965 |
$17M |
1.15% |
-
|
- |